Paris Cede, France

Françoise Baleux

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vestlandets Innovasjonsselskap as (Vis). Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Françoise Baleux. Retrieved from https://idiyas.com/inventor/francoise-baleux-3rjcq6zh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Françoise Baleux: Innovator in Antidiarrheal Vaccine Development

Introduction

Françoise Baleux is a prominent inventor based in Paris, France. She has made significant contributions to the field of vaccine development, particularly in creating innovative solutions for health challenges.

Latest Patents

Baleux holds a patent for "Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens." This invention aims to provide a new approach to combating diarrheal diseases, which are a major health concern worldwide. Her work in this area is crucial for improving public health outcomes.

Career Highlights

Throughout her career, Françoise Baleux has demonstrated a commitment to advancing medical science. She is associated with Vestlandets Innovasjonsselskap AS (Vis), where she continues to work on groundbreaking research and development projects.

Collaborations

Baleux has collaborated with notable colleagues, including Yves-Marie Coïc and Pål Puntervoll. These partnerships have enhanced her research efforts and contributed to the success of her projects.

Conclusion

Françoise Baleux is a trailblazer in the field of vaccine innovation, with her patent and collaborative efforts paving the way for advancements in healthcare. Her work exemplifies the impact of dedicated inventors on global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…